Updated ASCIA Action Plan for Drug (Medication) Allergy
The ASCIA Action Plan for Drug (Medication) Allergy has been updated in June 2021 and is now available on the ASCIA website www.allergy.org.au/hp/drug-allergy/ascia-action-plan-for-drug-medication-allergy
The changes made to this plan are consistent with the changes made to the 2021 versions of the red ASCIA Action Plan for Anaphylaxis and the green ASCIA Action Plan for Allergic Reactions. To read more go to www.allergy.org.au/about-ascia/info-updates/updated-ascia-action-plans
The need for an ASCIA Action Plan for Drug (Medication) Allergy and ASCIA Record for Drug (Medication) Allergy was identified by the ASCIA Drug Allergy committee a few years ago and development of the first versions was completed in 2020. There have also been requests for the plan for patients and parents of children who have medication allergies.
For children who have an allergy to a nonsteroidal anti-inflammatory drug (NSAIDs) such as paracetamol or ibuprofen the ASCIA Action Plan for Drug (Medication) Allergy can now be provided to their school or children’s education/care (CEC) service.
The ASCIA Action Plan for Drug (Medication) Allergy is a medical document that can only be completed by the patient's doctor and cannot be altered without their permission. This plan should be used in conjunction with the patient’s ASCIA Record for Drug (Medication) Allergy, which has also been updated in 2021.
The ASCIA Drug Allergy Committee includes leading clinical immunology/allergy specialists from Australia and New Zealand. The committee is Chaired by Professor Connie Katelaris AM, who took ove this role in September 2020 from Professor Michaela Lucas (current ASCIA President), who both played a significant role in the development of these documents.
Content created June 2021